PGLLDLK

ID: ALA227038

Max Phase: Preclinical

Molecular Formula: C35H62N8O10

Molecular Weight: 754.93

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C35H62N8O10/c1-19(2)14-24(39-28(44)18-38-30(47)22-11-9-13-37-22)31(48)41-26(16-21(5)6)33(50)43-27(17-29(45)46)34(51)42-25(15-20(3)4)32(49)40-23(35(52)53)10-7-8-12-36/h19-27,37H,7-18,36H2,1-6H3,(H,38,47)(H,39,44)(H,40,49)(H,41,48)(H,42,51)(H,43,50)(H,45,46)(H,52,53)/t22-,23-,24-,25-,26-,27-/m0/s1

Standard InChI Key:  GDWOWKAUHZNVKO-QCOJBMJGSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 754.93Molecular Weight (Monoisotopic): 754.4589AlogP: -0.89#Rotatable Bonds: 25
Polar Surface Area: 287.25Molecular Species: ZWITTERIONHBA: 10HBD: 10
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.72CX Basic pKa: 10.19CX LogP: -5.63CX LogD: -5.63
Aromatic Rings: 0Heavy Atoms: 53QED Weighted: 0.05Np Likeness Score: 0.11

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source